Towards a more personalized approach to the best standard of care and potential cure for PLHIV

2000HIV is part of the human functional genomics project (HFGP) that aims to improve our understanding of the variability of immune responses in human population. Exploring how this variability relates to susceptibility to immune mediated diseases and to the response to immune based therapies.

The 2000HIV study aims to discover new biological pathways and identify biomarkers that play a role in:

More about the 2000HIV project:

The 2000HIV project collaborations

Our multidisciplinary research team consists of researchers from academic institutions in the Netherlands, Germany, Austria, and Belgium, as well as VIIV Healthcare®.

Publications

Virulent HIV-1B: Clinical challenges and proteomic insights

16 januari 2025 | by Kavita Mehta | Abstract accepted for poster presentation at CROI annual meeting 9-12 March 2025

CCR5 expression is critical for the maintenance of HIV control and reservoir size

16 januari 2025 | by Jéssica dos Santos | Abstract accepted for poster presentation at CROI annual meeting 9-12 March 2025

Heterogeneity of PD-1 expression in PLHIV and its relationship with host- and viral-related factors

16 januari 2025 | by Adriana Navas | Abstract accepted for poster presentation at CROI annual meeting 9-12 March 2025